Search for:

Dr. iur. Julia Schieber

Julia is a partner in Baker McKenzie's IP and Technology team. She is specialized in IP transactional matters with a particular focus on the healthcare industry. Prior to joining Baker McKenzie, Julia worked for major law firms in Munich and New York City, and as a lecturer and research associate at the University of Konstanz. In 2018, she was seconded to Novartis. Julia has been ranked as a "rising star" for Life Sciences in Switzerland by Legal 500, and for Intellectual Property by Managing IP. Julia is heavily involved in the Firm's children's rights pro bono work.

The Federal Information Security Act (ISA), which only entered into force on 1 January 2024, is already being amended with an obligation to report cyberattacks for operators of critical infrastructures. On 18 January 2024, the deadline expired for challenging the amendment by way of a public referendum. This means that the amended version will become law, with the new obligation to report cyberattacks expected to come into force in 2025, although an exact date has not yet been set.

In its decision of 12 September 2022, the Swiss Federal Administrative Court confirmed that interpretive software that uses indicators such as calendar days and body temperature to monitor fertile and infertile phases of a menstrual cycle to achieve natural conception or prevent undesired pregnancy, qualifies as a medical device. This means that such software is subject to a conformity certification procedure with a notified body.